255 related articles for article (PubMed ID: 28964116)
1. Revealing kinetics and state-dependent binding properties of I
Ellinwood N; Dobrev D; Morotti S; Grandi E
Chaos; 2017 Sep; 27(9):093918. PubMed ID: 28964116
[TBL] [Abstract][Full Text] [Related]
2.
Ellinwood N; Dobrev D; Morotti S; Grandi E
Front Pharmacol; 2017; 8():799. PubMed ID: 29163179
[TBL] [Abstract][Full Text] [Related]
3. Rate-Dependent Role of I
Aguilar M; Feng J; Vigmond E; Comtois P; Nattel S
Biophys J; 2017 May; 112(9):1997-2010. PubMed ID: 28494969
[TBL] [Abstract][Full Text] [Related]
4. Human electrophysiological and pharmacological properties of XEN-D0101: a novel atrial-selective Kv1.5/IKur inhibitor.
Ford J; Milnes J; Wettwer E; Christ T; Rogers M; Sutton K; Madge D; Virag L; Jost N; Horvath Z; Matschke K; Varro A; Ravens U
J Cardiovasc Pharmacol; 2013 May; 61(5):408-15. PubMed ID: 23364608
[TBL] [Abstract][Full Text] [Related]
5. In silico study on the effects of IKur block kinetics on prolongation of human action potential after atrial fibrillation-induced electrical remodeling.
Tsujimae K; Murakami S; Kurachi Y
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H793-800. PubMed ID: 18055524
[TBL] [Abstract][Full Text] [Related]
6. Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model.
Courtemanche M; Ramirez RJ; Nattel S
Cardiovasc Res; 1999 May; 42(2):477-89. PubMed ID: 10533583
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of hesperetin on Kv1.5 potassium channels stably expressed in HEK 293 cells and ultra-rapid delayed rectifier K(+) current in human atrial myocytes.
Wang H; Wang HF; Wang C; Chen YF; Ma R; Xiang JZ; Du XL; Tang Q
Eur J Pharmacol; 2016 Oct; 789():98-108. PubMed ID: 27397430
[TBL] [Abstract][Full Text] [Related]
8. Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes.
Wang Z; Fermini B; Nattel S
J Pharmacol Exp Ther; 1995 Jan; 272(1):184-96. PubMed ID: 7815332
[TBL] [Abstract][Full Text] [Related]
9. Potassium Channel Blockade Enhances Atrial Fibrillation-Selective Antiarrhythmic Effects of Optimized State-Dependent Sodium Channel Blockade.
Aguilar M; Xiong F; Qi XY; Comtois P; Nattel S
Circulation; 2015 Dec; 132(23):2203-11. PubMed ID: 26499964
[TBL] [Abstract][Full Text] [Related]
10. The positive frequency-dependent electrophysiological effects of the IKur inhibitor XEN-D0103 are desirable for the treatment of atrial fibrillation.
Ford J; Milnes J; El Haou S; Wettwer E; Loose S; Matschke K; Tyl B; Round P; Ravens U
Heart Rhythm; 2016 Feb; 13(2):555-64. PubMed ID: 26455450
[TBL] [Abstract][Full Text] [Related]
11. Atrial-selective K
Ravens U
Can J Physiol Pharmacol; 2017 Nov; 95(11):1313-1318. PubMed ID: 28738160
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Anti-arrhythmic Effects in Human Atria with Combined Use of Sodium Blockers and Acacetin.
Ni H; Whittaker DG; Wang W; Giles WR; Narayan SM; Zhang H
Front Physiol; 2017; 8():946. PubMed ID: 29218016
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation in the goat induces changes in monophasic action potential and mRNA expression of ion channels involved in repolarization.
van der Velden HMW ; van der Zee L; Wijffels MC; van Leuven C; Dorland R; Vos MA; Jongsma HJ; Allessie MA
J Cardiovasc Electrophysiol; 2000 Nov; 11(11):1262-9. PubMed ID: 11083247
[TBL] [Abstract][Full Text] [Related]
14. Atrial selectivity of antiarrhythmic drugs.
Ravens U; Poulet C; Wettwer E; Knaut M
J Physiol; 2013 Sep; 591(17):4087-97. PubMed ID: 23732646
[TBL] [Abstract][Full Text] [Related]
15. Raloxifene inhibits transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes.
Liu H; Jin MW; Xiang JZ; Huang Y; Sun HY; Chiu SW; Lau CP; Li GR
Eur J Pharmacol; 2007 Jun; 563(1-3):61-8. PubMed ID: 17337266
[TBL] [Abstract][Full Text] [Related]
16. Potassium channel blocking 1,2-bis(aryl)ethane-1,2-diamines active as antiarrhythmic agents.
Kajanus J; Antonsson T; Carlsson L; Jurva U; Pettersen A; Sundell J; Inghardt T
Bioorg Med Chem Lett; 2019 May; 29(10):1241-1245. PubMed ID: 30879840
[TBL] [Abstract][Full Text] [Related]
17. Pathology-specific effects of the IKur/Ito/IK,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation.
Christ T; Wettwer E; Voigt N; Hála O; Radicke S; Matschke K; Várro A; Dobrev D; Ravens U
Br J Pharmacol; 2008 Aug; 154(8):1619-30. PubMed ID: 18536759
[TBL] [Abstract][Full Text] [Related]
18. Can inhibition of IKur promote atrial fibrillation?
Burashnikov A; Antzelevitch C
Heart Rhythm; 2008 Sep; 5(9):1304-9. PubMed ID: 18774108
[TBL] [Abstract][Full Text] [Related]
19. Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation.
Van Wagoner DR; Pond AL; McCarthy PM; Trimmer JS; Nerbonne JM
Circ Res; 1997 Jun; 80(6):772-81. PubMed ID: 9168779
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of I
Juhász V; Hornyik T; Benák A; Nagy N; Husti Z; Pap R; Sághy L; Virág L; Varró A; Baczkó I
Can J Physiol Pharmacol; 2018 Jan; 96(1):18-25. PubMed ID: 28892643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
